Immunotherapy for ovarian cancer: what are the targets of the future?

被引：11
|
作者：
Adams, Sarah F. [1 ]
Benencia, Fabian [2 ]
机构：
[1] Univ New Mexico, Ctr Canc, Gynecol Oncol, Albuquerque, NM 87131 USA
[2] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Acad Res Ctr 202C, Athens, OH 45701 USA
来源：
FUTURE ONCOLOGY | 2015年 / 11卷 / 09期
关键词：
chemotherapy; immunotherapy; ovarian cancer; tumor microenvironment; LIPOSOMAL DOXORUBICIN; T-CELLS;
D O I：
10.2217/fon.15.44
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1293 / 1296
页数：4
相关论文
共 50 条
  • [41] Is there a role for immunotherapy in ovarian cancer?
    Giannone, Gaia
    Valabrega, Giorgio
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [42] IMMUNOTHERAPY FOR OVARIAN CANCER - REPLY
    HUDSON, CN
    LANCET, 1976, 2 (7996): : 1195 - 1195
  • [43] Immunotherapy opportunities in ovarian cancer
    Chu, Christina S.
    Kim, Sarah H.
    June, Carl H.
    Coukos, George
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (02) : 243 - 257
  • [44] Immunotherapy in ovarian and endometrial cancer
    Pignata, Sandro
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [45] Immunotherapy in Recurrent Ovarian Cancer
    Chen, Keyao
    Wang, Jingjing
    Yang, Meng
    Deng, Shaoqiong
    Sun, Li
    BIOMEDICINES, 2025, 13 (01)
  • [46] Ovarian cryopreservation: What future?
    Mirallie, S.
    Freour, T.
    Barriere, P.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2012, 40 (11): : 684 - 686
  • [47] What is the future of immunotherapy in multiple myeloma?
    Rasche, Leo
    Hudecek, Michael
    Einsele, Hermann
    BLOOD, 2020, 136 (22) : 2491 - 2497
  • [48] Monitoring immunotherapy with biomarkers: What will be the future?
    Shamji, M.
    ALLERGOLOGIE, 2021, 44 (08) : 647 - 647
  • [49] FUTURE IMMUNOTHERAPY - WHAT LIES AHEAD
    GORDON, BR
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1995, 113 (05) : 603 - 605
  • [50] IDENTIFICATION OF BIOMARKERS AND TARGETS FOR THE IMMUNOTHERAPY OF PATIENTS WITH CLEAR CELL OVARIAN CANCER: A SYSTEMATIC LITERATURE REVIEW
    Butler, H.
    Glasspool, R.
    Guinn, B-A
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A99 - A100
12345